Skip to Content Skip to Content

Health Sciences

Reset All Filters
2001 Results
Penn Vet Team Identifies New Therapeutic Targets for the Tropical Disease Leishmaniasis

Penn Vet Team Identifies New Therapeutic Targets for the Tropical Disease Leishmaniasis

Each year, about 2 million people contract leishmaniasis, a parasitic disease transmitted by the bite of a sand fly. The cutaneous form of the disease results in disfiguring skin ulcers that may take months or years to heal and in rare cases can become metastatic, causing major tissue damage.

Katherine Unger Baillie

Tired Teens More Likely to Commit Crimes as Adults

Tired Teens More Likely to Commit Crimes as Adults

Teenagers who self-report feeling drowsy mid-afternoon also tend to exhibit more anti-social behavior such as lying, cheating, stealing and fighting.

Michele W. Berger

Q&A with Victoria Ferguson
Victoria Ferguson

Q&A with Victoria Ferguson

Midwives have been around since Moses. In the Book of Exodus, it was written that the pharaoh of Egypt, terrified of the multiplying and flourishing Israelis, ordered the murder of all newborn Hebrew sons, “but the midwives feared God, and did not as the king of Egypt commanded them, but saved the men children alive.”

T Cells Support Long-lived Antibody-producing Cells, Penn-led Team Finds

T Cells Support Long-lived Antibody-producing Cells, Penn-led Team Finds

If you’ve ever wondered how a vaccine given decades ago can still protect against infection, you have your plasma cells to thank. Plasma cells are long-lived B cells that reside in the bone marrow and churn out antibodies against previously encountered vaccines or pathogens.

Katherine Unger Baillie

Penn Medicine: Gene Search Reveals New Mutations, Drug Targets in Rare Adrenal Tumors

Penn Medicine: Gene Search Reveals New Mutations, Drug Targets in Rare Adrenal Tumors

Casting one of the largest genomic nets to date for the rare tumors of the autonomic nervous system known as pheochromocytoma and paraganglioma (PCC/PGL) captured several new mutations driving the disease that could serve as potential drug targets, researchers from Penn Medicine and other institutions reported in 

John Infanti

Plant-made Hemophilia Therapy Shows Promise, Penn Study Finds

Plant-made Hemophilia Therapy Shows Promise, Penn Study Finds

People with hemophilia require regular infusions of clotting factor to prevent them from experiencing uncontrolled bleeding. But a significant fraction develop antibodies against the clotting factor, essentially experiencing an allergic reaction to the very treatment that can prolong their lives.

Katherine Unger Baillie

CHOP/Penn/Boston Children’s Study: Low Blood Sugar No Benefit to Critically Ill Children

CHOP/Penn/Boston Children’s Study: Low Blood Sugar No Benefit to Critically Ill Children

Critically ill infants and children do not gain extra benefit from lower blood-sugar levels, compared to higher levels within the usual care range, according to research from the Children’s Hospital of Philadelphia, the University of Pennsylvania

Michele W. Berger

Anti-Inflammatory, Anti-Cell Death Agent a Potential Treatment for Vision Loss Associated with Multiple Sclerosis

Anti-Inflammatory, Anti-Cell Death Agent a Potential Treatment for Vision Loss Associated with Multiple Sclerosis

A new therapeutic agent tested in a mouse model of multiple sclerosis (MS) produced anti-inflammatory activity and prevented loss of cells in the optic nerve, according to a new study by researchers in the Perelman School of Medicine at the University of Pennsylvania, with Pittsburgh-based Noveome Biotherapeutics.

Karen Kreeger